Fiber-Modified Adenovirus for Central Nervous System Parkinson’s Disease Gene Therapy

Author： Lewis Travis B. Glasgow Joel N. Harms Ashley S. Standaert David G. Curiel David T.

Publisher： MDPI

E-ISSN： 1999-4915|6|8|3293-3310

ISSN： 1999-4915

Source： Viruses, Vol.6, Iss.8, 2014-08, pp. : 3293-3310

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gene Therapy for the Treatment of Parkinson’s Disease: The Nature of the Biologics Expands the Future Indications

By Fiandaca Massimo S. Bankiewicz Krystof S. Federoff Howard J.

Pharmaceuticals, Vol. 5, Iss. 6, 2012-06 ,pp. : 553-590

MDPI

Access to resources Recommend Favorite

Protein Kinases and Parkinson’s Disease

By Mehdi Syed Jafar Rosas-Hernandez Hector Cuevas Elvis Lantz Susan M. Barger Steven W. Sarkar Sumit Paule Merle G. Ali Syed F. Imam Syed Z.

International Journal of Molecular Sciences, Vol. 17, Iss. 9, 2016-09 ,pp. : 1585-1585

MDPI

Access to resources Recommend Favorite

Hypermethylation of Synphilin-1, Alpha-Synuclein-Interacting Protein (SNCAIP) Gene in the Cerebral Cortex of Patients with Sporadic Parkinson’s Disease

By Dashtipour Khashayar Tafreshi Ali Adler Charles Beach Thomas Chen Xin Serrano Geidy Tashiro Stephanie Wang Charles

Brain Sciences, Vol. 7, Iss. 7, 2017-06 ,pp. : 74-74

MDPI

Access to resources Recommend Favorite

Analysis of Epidermal Growth Factor Receptor Related Gene Expression Changes in a Cellular and Animal Model of Parkinson’s Disease

By Kim In-Su Koppula Sushruta Park Shin-Young Choi Dong-Kug

International Journal of Molecular Sciences, Vol. 18, Iss. 2, 2017-02 ,pp. : 430-430

MDPI

Access to resources Recommend Favorite

Mitochondria: A Therapeutic Target for Parkinson’s Disease?

By Luo Yu Hoffer Alan Hoffer Barry Qi Xin

International Journal of Molecular Sciences, Vol. 16, Iss. 9, 2015-09 ,pp. : 20704-20730

MDPI

Access to resources Recommend Favorite